20 August 2026
A Moderna-Merck melanoma vaccine reduces recurrence and spread in a late-stage trial, boosting hopes for mRNA cancer treatments.
27 July 2026
Aspen HIV prevention pill licensing deal positions the SA manufacturer to supply lower-cost monthly PrEP across key African markets.
11 June 2026
Uncover the potential of mRNA vaccines that show promise for personalized cancer treatments that target tumor cells effectively.
29 June 2025
Explore immunotherapy for cancer and its transformative impact on treatment at earlier stages, improving survival rates.